Related Experiment Video
Updated: Feb 16, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Shivering Treatments for Targeted Temperature Management: A Review
Akash Jain1, Maria Gray, Stephanie Slisz
1Questions or comments about this article may be directed to Akash Jain, MBBS, at akashjain2019@gmail.com. Medical Officer, Government of Rajasthan, India. Maria Gray, MA RN, is Vice President for Clinical Services, Attune Medical, Chicago, IL. Stephanie Slisz, BSN RN, is Senior Clinical Specialist, Attune Medical, Chicago, IL. Joseph Haymore, DNP ACNP, is Senior Nurse Practitioner and Advanced Practice Provider Research Director, Neurocritical Care Intensive Care Unit, University of Maryland Medical Center, Baltimore, Maryland. Neeraj Badjatia, MD, is Professor of Neurology and Vice Chair for Hospital Operations, Department of Neurology, University of Maryland School of Medicine and R Adams Cowley Shock Trauma Center, Baltimore, MD. Erik Kulstad, MD MS, is Associate Professor, Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Background:
Shivering is common during targeted temperature management, and control of shivering can be challenging if clinicians are not familiar with the available options and recommended approaches.
Purpose:
The purpose of this review was to summarize the most relevant literature regarding various treatments available for control of shivering and suggest a recommended approach based on latest data.
Methods:
The electronic databases PubMed/MEDLINE and Google Scholar were used to identify studies for the literature review using the following keywords alone or in combination: "shivering treatment," "therapeutic hypothermia," "core temperature modulation devices," and "targeted temperature management."
Results:
Nonpharmacologic methods were found to have a very low adverse effect profile and ease of use but some limitations in complete control of shivering. Pharmacologic methods can effectively control shivering, but some have adverse effects, such that risks and benefits to the patient have to be balanced.
Conclusion:
An approach is provided which suggests that treatment for shivering control in targeted temperature management should be initiated before the onset of therapeutic hypothermia or prior to any attempt at lowering patient core temperature, with medications including acetaminophen, buspirone, and magnesium sulfate, ideally with the addition of skin counterwarming. After that, shivering intervention should be determined with the help of a shivering scale, and stepwise escalation can be implemented that balances shivering treatment with sedation, aiming to provide the most shivering reduction with the least sedating medications and reserving paralytics for the last line of treatment.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Body Temperature
Body Temperature
The average body temperature is approximately 37°C (98.6°F) and typically ranges from 36.1–37.2°C...
Effects of Temperature on Free Energy
Factors Affecting Body Temperature
Factors may include:

